Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Dendritic cells: Steinman, R.M.
- Dendritic cells
- DC subtypes characteristics
- DC subtypes characteristics: update (1)
- DC subtypes characteristics: update (2)
- Dendritic cells in the eye: the conjunctiva
- How dendritic cells regulate the immune response
- The many ways to mature a dendritic cell
- DC regulation in the eye and blood stream
- DC - summary
- Ocular dendritic cells
- DC in the corneal epithelium and stroma
- MHC class II+ cells in the central cornea
- DC in corneal layers
- Corneal stromal leukocytes
- Plasmacytoid dendritic cells in normal cornea
- Nanotube connection between DC in the cornea
- Resident macrophages and DC in the uveal tract
- Two different DC types in the choroid
- MHC class II+ DC in the retina
- DC and T cell interactions in ocular inflammation
- How does ocular antigen get to the T cell? (1)
- How does ocular antigen get to the T cell? (2)
- Two studies of antigen trafficking
- Soluble antigen applied to abraded cornea (1)
- Soluble antigen applied to abraded cornea (2)
- Soluble antigen applied to abraded cornea (3)
- Lymph node DC process cornea-derived antigen
- Cell-associated antigen applied to abraded cornea
- Antigen-specific expansion of T lymphocytes
- Does antigen get from retina to the DLN?
- 3A9 cells fail to divide in IRBP-HEL recipients
- Breaking tolerance and losing privilege
- Breaking tolerance/losing privilege: graft rejection
- T cell precursory frequency vs. T cell priming
- T cells in the host DLN after corneal graft
- Corneal graft rejection generates T cell memory
- Breaking tolerance: herpes simplex keratitis
- Herpes simplex keratitis - RE strain
- Breaking tolerance: models of autoimmunity
- Cell infiltration in the EAU retina
- Experimental autoimmune uveoretinitis onset
- EAU - later disease
- EAU progression occurs at post-capillary venule
- Spontaneous EAU in transgenic IRBP-HEL mice
- T cell expansion in LN: EAU spontaneous model
- Adoptive Tx of HEL-activated 3A9 CD4 T cells
- EAU in the Lewis rat
- Tx S-Ag specific T cells activate only in the eye
- Controlling inflammation/restoring tolerance
- Immunological privilege and the eye
- Restoring tolerance/regaining privilege
- Restoring tolerance/regaining privilege: questions
- Experimental protocol
- LPS-activated IL-10 secreting DC inhibit EAU
- MHC class II isn't required for inhibition of EAU
- sc. inoculated IL10-secreting DC
- Effect of IL10-DC treatment on spontaneous EAU
- Does eDC inhibit the spontaneous EAU?
- eDC treatment effect in the posterior segment
- Effect of Tregs on spontaneous EAU
- Conclusion
- Acknowledgements
Topics Covered
- Ocular inflammation (uveitis, corneal disease)
- Infectious and non-infectious
- Role of antigen presenting cells (dendritic cells)
- Organ specific autoimmunity (retinal damage)
- Corneal graft rejection
- Influence of immune privilege on ocular inflammation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Forrester, J.V. (2014, May 5). Dendritic cells and the eye: their role in the ocular immune response [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/HRBX5472.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. John V. Forrester has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Ophthalmology
Transcript
Please wait while the transcript is being prepared...
0:00
This is
a Henry Stewart talk,
and I'm John Forrester from the
University of Aberdeen, Scotland.
My presentation is on
dendritic cells in the eye
and their role in the
ocular immune response.
0:13
Dendritic cells were discovered
by Ralph Steinman in 1973.
Steinman and Cohn reported this
in the Journal of Experimental
Medicine of a novel cell type in the
peripheral lymphoid organs of mice.
Later Ralph Steinman identified
these as the most potent antigen
presenting cells promoting
the adaptive immune response.
And he also later
identified them, in fact,
as having a major role in
homeostasis of the immune response
by promoting non-responsiveness to
immune stimulation, i.e. tolerance.
For this work he had
international recognition in 2007
with the Lasker Award,
and most recently
has been awarded the
Nobel Prize for this work.
1:01
The ontogeny of dendritic
cells is interesting.
They arise as
hematopoietic precursors
as stem cells in the bone marrow.
And the lineage of these, of
course, is to produce macrophages
and a subset of
myeloid dendritic cells
called, conventional dendritic cells.
There is also a smaller population
of CD34 myeloid precursor
cells which enter the bloodstream,
and these may produce
a subset of cells
called the plasmacytoid
dendritic cells.
There has been a suggestion
that this other cell type,
the plasmacytoid
dendritic cell, may also
arise from a lymphoid precursor.
But it's generally believed that
in fact, this is not correct,
and most of this small
subset of dendritic cells
arises from the bone marrow.
Whether or not the
plasmacytoid dendritic cell
has a separate lineage from
the conventional dendritic cell
is unclear, but they
certainly do appear
to have specific and selective
transcription factors,
such as the E2-2
transcription factor,
which is, in the absence
of this, the possibility
that the plasmacytoid
dendritic cell can revert
to a conventional
dendritic cell might arise.
Hide